Overview

A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of single dosing study with three ascending dose cohorts of ISU302 in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
ISU Abxis Co., Ltd.